---
$id: https://graph.org.ai/products/commodity/51172153
$type: Product
source: UNSPSC
code: "51172153"
title: "Trospium"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trospium

**UNSPSC Code**: 51172153
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C25H30NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T4Y8ORK057, chemically known as 6,10-ethano-5-azoniaspiro(4.5)decan-8-ol, chloride, benzilate but generally known as trospium, which bears US NIH Compound Identifier 107979. European Medicines Agency schedules Trospium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05000MIG. World Health Organization schedules trospium in its Anatomical Therapeutic Chemical (ATC) Classification. TROSPIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, TROSPIUM remains the US FDA Preferred Term for this commodity. Trospium bears US NLM identifiers UMLS ID C0772089 and NCI Concept Code C78080. SMILES: CL.O(C1CC2[N]3(C(CC2)C1)CCCC3)C(=O)C(O)(C1CCCCC1)C1CCCCC1. .

